ADAR2 deficiency ameliorates non‐alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1

• Main Authors: Mei‐Lang Kung (Author), Tai‐Hua Yang (Author), Chia‐Chi Lin (Author), Jia‐Yun Ho (Author), Tzu‐Chi Hung (Author), Chih‐Hsiang Chang (Author), Kuan‐Wen Huang (Author), Chien‐Chin Chen (Author), Yun‐Wen Chen (Author)
• Format: Book
• Published: Wiley, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Non‐alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength, which is commonly associated with NAFLD. Adenosine‐to‐inosine ed...